A meta-analysis of randomized controlled trials finds saffron performed similarly to common antidepressants while reporting fewer adverse effects.
By yourNEWS Media Newsroom
An analysis of clinical trials has found that saffron, a spice used for centuries in traditional medicine, demonstrated comparable effectiveness to commonly prescribed SSRI antidepressants in reducing symptoms of depression and anxiety.
The findings come from a meta-analysis published in Nutrition Reviews that examined eight randomized controlled trials directly comparing saffron supplementation with prescription selective serotonin reuptake inhibitors. Across the studies, researchers reported no significant difference in symptom reduction between saffron and pharmaceutical antidepressants.
Participants in the trials typically received 30 milligrams per day of standardized saffron extract. At that dosage, saffron matched the antidepressant effects of SSRIs used in the comparison groups.
The review also noted differences in tolerability. According to the analysis, participants taking saffron experienced a 6 percent lower absolute risk of adverse events compared with those taking pharmaceutical antidepressants. SSRIs are commonly associated with side effects including sexual dysfunction, weight changes, emotional blunting, and withdrawal symptoms in some patients.
Researchers attribute saffron’s effects to its bioactive compounds, including crocin and safranal. Studies suggest these compounds may influence multiple neurotransmitter systems, including serotonin, dopamine, and norepinephrine. In addition to neurotransmitter activity, saffron has demonstrated antioxidant and anti-inflammatory properties in laboratory and clinical research.
The multi-system activity differs from the mechanism of SSRIs, which primarily function by blocking serotonin reuptake. Researchers have suggested that saffron’s broader biological effects may contribute to its clinical outcomes.
Beyond mood-related findings, additional studies have examined saffron’s potential role in supporting eye health. Research on age-related macular degeneration has reported improvements in measures such as contrast sensitivity, color perception, and reading ability among individuals supplementing with saffron.
Clinical trials examining mood outcomes have focused on standardized extracts rather than culinary amounts used in cooking. Experts caution that supplement quality, dosing, and medical supervision remain important considerations for individuals seeking to address depression or anxiety.
Saffron has a long history of medicinal use across Persian, South Asian, and Mediterranean cultures. The recent analysis reflects an increasing scientific interest in evaluating traditional remedies through controlled clinical research.
While the meta-analysis supports saffron’s potential as an alternative option in certain cases, mental health professionals emphasize that treatment decisions should be individualized and guided by qualified healthcare providers, particularly for individuals with moderate to severe depression.
The findings add to a growing body of research exploring nutritional and botanical approaches alongside conventional psychiatric treatments, highlighting continued investigation into the range of options available for mood disorders.
Source: Natural News
Original article
Comments